• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Neuroscience
  • Seroquel XR in the long term treatment of schizophrenia focus on affective symptoms

Disease
schizophrenia
Drug Name
Seroquel XR
Generic Name
quetiapine fumarate
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Non-Interventional Study
Start Date
Sep 20, 2010
Study Name
NIS-NHU-SER-2010/1
Study Id
NIS-NHU-SER-2010/1
ClinicalTrials.gov ID
NCT01202617
Recruiting Status
Closed
Protocol Status
Not Available
Report
Sep 25, 2012
  • NIS-NHU-SER-2010-1.pdf (117 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013